TriLinc Global Impact Fund LLC

TriLinc Global Impact Fund LLC is a U.S.-based investment fund organized as a limited liability company that provides debt financing through a network of wholly owned subsidiary investment vehicles. Its portfolio is focused on lending to businesses across emerging and frontier markets in Asia, Africa, Latin America, Europe, and North America, with a particular emphasis on trade finance and operating-company loans.

— TriLinc Global Impact Fund LLC
%
Direct lending45% Loans made to operating companies for working capital, growth, or refinancing needs.
Trade finance30% Shorter-duration financing tied to trade receivables, inventory, or cross-border commerce.
Regional investment vehicles15% Subsidiary funds and special-purpose entities used to deploy capital by geography.
Impact investing10% Debt investments structured to support measurable social and economic outcomes.

The fund lends to privately held businesses that need non-bank financing, especially companies operating in emerging...

  • Operating companies in emerging marketsprimary

    Borrowers use term loans or structured debt for expansion, refinancing, or liquidity support.

  • Trade finance borrowersprimary

    Companies financing receivables, inventory, and cross-border trade flows.

  • Regional portfolio companiessecondary

    Businesses in Asia, Africa, Latin America, Europe, and North America financed through regional subsidiaries.

  • Impact-oriented sponsors and borrowerssecondary

    Counterparties seeking capital aligned with social and economic development goals.

The fund deploys capital through subsidiaries organized around Asia, Africa, Latin America, Europe, and North America,...

  • •Loans have been made in South America, Asia, Africa, North America, and Europe
  • •Subsidiaries are organized by region and strategy, including trade finance vehicles
  • •Emerging-market exposure increases sensitivity to local legal and currency conditions
  • •Cross-border lending requires country-specific underwriting and servicing

The fund’s strategy is to originate and manage private credit investments across multiple emerging-market regions...

01
Maintain diversified regional lending platformsmedium-term

Diversification reduces concentration risk across countries and sectors.

02
Originate attractive private credit opportunitiesshort-term

The fund relies on sourcing borrowers that need non-bank capital and can support structured lending terms.

03
Preserve credit quality through underwriting and monitoring

Loan performance drives asset values, income, and recoveries in a private credit portfolio.

The main risks are borrower credit deterioration, country and currency volatility, and legal or restructuring...

high

Borrower credit deterioration

The portfolio consists of private loans where repayment depends on borrower cash flow and collateral value.

Scope
Direct lending and trade finance portfolio
Materiality
high
high

Emerging-market country risk

Lending spans multiple jurisdictions with different legal systems, enforcement regimes, and macro conditions.

Scope
Asia, Africa, Latin America, Europe, North America
Materiality
high
high

Workout and restructuring risk

Problem loans may require restructuring, court approval, or extended recovery timelines.

Scope
Distressed or underperforming borrowers
Materiality
high
medium

Currency and transfer risk

Cross-border lending can be affected by FX movements and restrictions on moving cash across borders.

Scope
Non-U.S. borrowers and subsidiaries
Materiality
medium
Fair value of illiquid loans
Can materially change net asset value and investment income
Impairment and collectability
Can reduce reported earnings and asset values
Restructuring accounting
Can change timing of income and recovery estimates

Triller Group Inc.

ILLR · Investment Advice

SOLIGENIX, INC.

SNGX · Pharmaceutical Preparations

Global Indemnity Group, LLC

GBLI · Fire, Marine & Casualty Insurance

DYADIC INTERNATIONAL INC

DYAI · Biological Products, (No Diagnostic Substances)

Tri-County Financial Group, Inc.

TYFG · State Commercial Banks

Gain Therapeutics, Inc.

GANX · Pharmaceutical Preparations

: 29.4.2026